Strong market presence: LifeHealthcare Group Ltd (ASX: LHC) enjoys top three market positions in core channels. The business model is focused on global sourcing and offering local solutions with emphasis on specialty clinical channels and products like spine, neurosurgery, orthopedics, ultrasound and coronary intervention. Meanwhile, the group’s revenues have grown at a CAGR of 10.3% since the last five years while EBITDA grew 14.3% during the same period. Moreover, the demand outlook remains positive with rising aging population, emerging technology and rising rate of chronic disease.